ABBVIE

Company profile

AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Sales are distributed geographically as follows: the United States (62.2%), Germany (4.3%), the United Kingdom (3%), Japan (3%), France (2.8%), Canada (2.4%), Spain (2.3%), Italy (2%), Brazil (1.4%), the Netherlands (1.4%) and other (15.2%).

Source: Cofisem - Last Update: 27 Oct 2017

Key Executives

Chairman and Chief Executive Officer	Richard A. Gonzalez
General Secretary	Laura J. Schumacher
Chief Financial Officer	William J. Chase
Human Resources Director	Timothy J. Richmond
Director Research & Development	Michael Severino
Source: Cofisem - Last Update: 09 Jun 2017

Key figures

Millenium	2016	2015	2014	2013	2012
Net sales	24.334.636	21.696.912	18.945.290	17.834.770	17.445.612
Cost of sales	5.536.466	4.271.232	4.200.994	4.348.115	4.278.826
Payroll
Operating income	8.906.944	7.153.840	3.237.594	5.376.058	5.521.280
Taxes	1.832.833	1.424.693	564.751	1.142.792	427.123
Net income	5.650.366	4.882.493	1.683.814	3.918.144	5.006.834
Group net income	5.650.366	4.882.493	1.683.814	3.918.144	5.006.834
Fiscal year end	12,16	12,15	12,14	12,13	12,12
Length of fiscal year (month)	12	12	12	12	12
Currency & Unit	EUR - thousands	EUR - thousands	EUR - thousands	EUR - thousands	EUR - thousands
Account Standards
Source: Cofisem - Last Update: 27 Oct 2017

Shareholder information

	50,16 %
BlackRock	6,10 %
The Vanguard Group	6,09 %
Source: Cofisem - Last Update: 22 Jun 2016

Company profile

Key Executives

Key figures

Shareholder information

Address